Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00467012
Recruitment Status : Completed
First Posted : April 27, 2007
Last Update Posted : April 26, 2012
Information provided by (Responsible Party):
Chugai Pharmaceutical

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2009
  Study Completion Date : September 2011